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Cadmium compounds are highly toxic substances characterized by mutagenic, genotoxic and carcinogenic effects, and having high 
cumulative properties. Application of cadmium nanoparticles (NPs) in medicine stimulates the study of their mechanism of action 
at the cellular level and at the level of organs and systems, determination of biomarkers of their action, particularly in comparison 
with the ionic form. The aim of the study was to compare the features of cytotoxic and genotoxic effects of cadmium sulfide (CdS) 
NPs of different sizes on cell cultures of different histogenesis with those of cadmium chloride (CdCl2). Materials and Methods: 
In this work, we used cadmium compounds in the nanoform: NPs CdS of 4–6 nm and of 9–11 nm in size; and in the ionic form: 
CdCl2. The studies were conducted in vitro in cell lines — IMR-32, НEК-293 and MАEC. To count viable cells we compared 
the results of three basic tests: MTT (methyl tetrasolium test), SRB (sulforhodamine B test) and NRU (neutral red uptake test). 
We evaluated the genotoxic effect of the substances studied in vitro using DNA comet assay in alkaline conditions. Results: CdS NPs 
and CdCl2 demonstrated pronounced dose-dependent cytotoxic effect in MАEC, НEК-293 and IMR-32 cell lines, by impairing 
membrane permeability, functioning of mitochondria and lysosomes, and inhibiting the function of protein synthesis. Cytotoxic 
effect of CdCl2 was the most pronounced, this effect of CdS NPs of 9–11 nm in size being the least pronounced. The comet DNA 
assay in alkaline conditions revealed a statistically significant increase in DNA comet index when exposed to CdCl2 and CdS NPs 
in comparison with the negative control, which indicates their genotoxic effect. CdS NPs of 4–6 nm in size showed a more pro-
nounced effect in comparison with those of 9–11 nm in size. Conclusion: Elucidation of mechanisms underlying the implementation 
of toxic effects of cadmium NPs will help in assessing the potential risks associated with their use in industry and developing effective 
preventive measures. For instance, when planning in vivo studies for toxicological evaluation of nanomaterials and nano-substances 
containing NPs of cadmium, it is necessary to investigate the mutagenic and carcinogenic risks and to take into account the high 
likelihood of neurotoxic and cardiovasotoxic effects, along with nephrotoxic effects, since high cytotoxic activity of the investigated 
compounds of cadmium was detected on the cells of the MАEC line (endothelial origin) and IMR-32 (neuronal origin).
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Such heavy metals as mercury, lead, cadmium 
and their compounds play the leading role among the 
global pollutants of the environment [1–5]. In case 
of acute exposure excessive amounts of cadmium 
may get into the body, potentially causing damage 
to the lungs, kidneys, liver, and reproductive organs, 
whereas in case of chronic exposure cadmium mainly 
has nephrotoxic, immunotoxic and osteotoxic ef-
fects [6, 7]. In general, cadmium compounds are 
highly toxic substances, characterized by mutagenic 
and genotoxic effects and having high cumulative 
properties.
Cadmium and cadmium compounds have been 
classified as known human carcinogens by the Interna-
tional Agency for Research on Cancer and the National 
Toxicology Program based on epidemiologic studies 
showing a causal association with lung cancer, and 
possibly prostate cancer, and studies in experimental 
animals, demonstrating that cadmium causes cancer 
development by various routes of exposure. Epide-
miologic studies published since these evaluations 
suggest that cadmium is also associated with cancer 
of the breast, kidney, pancreas, and urinary bladder, 
and non-Hodgkin lymphoma [8–11].
Development of nanotechnology has stimulated 
the initiation of research of the synthesis and action 
of nanoparticles (NPs) of heavy metals, in particular 
of lead [12–14], cadmium compounds and the like and 
their use in various industries. Cadmium-containing 
nanomaterials are extensively used in optical and elec-
tronic devices, in particular in semiconductor lasers, 
as parts of photocells, solar cells, photo- and light 
emitting diodes [15]. Quantum dots based on cad-
mium compounds can be used as biological labels 
when combined with certain proteins [16].
NPs have unique physico-chemical properties, 
which also determine their negative impact on the 
body. It is known, that toxicity of metal NPs and their 
compounds depends on the size, surface area, par-
ticle charge, basic material, dose, route of exposure, 
solubility and lifetime [17–19].
The introduction of cadmium compounds NPs into 
production necessitated the study of their mode of ac-
tion both on the cellular and the organ and systems 
levels, determination of biomarkers of their effects, 
especially in comparison with their ionic form. It should 
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be emphasized that research on in vitro models on hu-
man and animal cell cultures of different organ origin, 
in particular, is a mandatory stage of toxicological 
evaluation of new NPs and nanomaterials, which al-
lows for coordinated further experimental studies and 
significantly reduces the use of animals.
The results of Rodríguez-Fragoso et al. [20] 
showed that NPs of cadmium sulfide (CdS) stabilized 
by maltodextrin exhibited cytotoxic effects to-
ward HepG2, MDA-MB-231 and CaCo-2 cell 
cultures, induced apoptosis, stimulated increased 
production of reactive oxygen species (ROS) and 
cell proliferation. Pujalté et al. [21] showed that CdS 
NPs 7.65 ± 1.4 nm in size after 24 h incubation on the 
culture of kidney cells IR 15 (mesangial glomerular 
cells) and NL-2 (proximal tubular epithelium cells) 
caused morphological changes in the cells (irregular 
form of the nucleus, the appearance of vesicles), 
caused a dose-dependent cytotoxic effect, and en-
hanced formation of ROS. In low concentrations, they 
increased levels of glutathione, and decreased them 
in high concentrations.
The results of scientific studies revealed the follow-
ing underlying mechanisms of toxic effect of cadmium 
NPs: the development of oxidative stress and inhibi-
tion of antioxidant system activity, genotoxic effects 
and impairment of calcium homeostasis in the cell, 
stimulation of apoptosis [21–24].
Hossain [25] showed the toxic effect of synthe-
sized CdS NPs of 3 nm in size on E. coli and HeLa 
cells. For instance, the effects of CdS NPs changed 
the morphological features of bacterial cells, im-
paired the formation of cell walls, transcription and 
translation processes, and condensation and frag-
mentation of nuclei. HeLa cells have also undergone 
morphological changes, the LC50 of CdS NPs being 
4 μg/ml. A dose-dependent increase in the level 
of ROS in both E. coli and in HeLa cells when exposed 
to CdS NPs was recorded.
The novelty of the presented work lies in the 
fact that we studied the peculiarities of cytotoxic 
and genotoxic effects of CdS NPs of different sizes 
in comparison with the ionic form of cadmium for 
further toxicological evaluation of nanocompounds 
and nanomaterials containing cadmium compounds, 
and analyzed the potential occupational health risks, 
especially the risks of carcinogenic effects.
The aim of the study was to compare the speci-
ficities of cytotoxic and genotoxic effects of CdS NPs 
of various sizes with cadmium chloride (CdCl2) on cell 
cultures of different organ origin.
MATERIALS AND METHODS
The following NPs of cadmium were used 
in the work: CdS NPs with a mean size of 4–6 nm and 
of 9–11 nm in the ionic form CdCl2, which is well 
soluble in water. CdS NPs were obtained by chemi-
cal synthesis, using sodium polyphosphate stabilizer 
(NaPO3)n. NPs dimensions were determined by elec-
tron microscopy.
Specific features of the cadmium compounds 
cytotoxic activity were studied in vitro on cultures 
of IMR-32 cells (neuronal origin), НEК-293 (kidney 
cells) and MАEC (endothelial cells). All cell lines were 
obtained from the cell bank of the R.E. Kavetsky 
Institute of Experimental Pathology, Oncology and 
Radiobio logy of the National Academy of Sciences 
of Ukraine. The cells were cultured in a complete growth 
medium RPMI 1640 containing 4 mmol/l of L-glu-
tamine (IMR-32, НEК-293) or DMEM containing 
2 mM L-glutamine (MАEC) supplemented with 10% 
of fetal bovine serum and 40 μg/ml gentamicin 
in a humidified atmosphere with 5% СО2 at 37 °С. The 
medium was replaced every 2 days, and the cells were 
transferred with the trypsin solution in EDTA after they 
had formed a continuous monolayer.
To evaluate the cytotoxic activity of the cadmium 
compounds studied, the cells were plated on 96-well 
plates at a concentration of 1 • 105 cells per well in com-
plete growth medium. The next day the solutions of the 
investigated cadmium compounds in the nano- and ion 
forms in concentration of 1 • 10-3–4.6 • 10-7 mol/l were 
added to the cells followed by incubation for 24 h.
The cytotoxic activity of the cadmium compounds 
were evaluated by the indicators of cellular functional 
activity in the following tests: in the methyl tetraso-
lium test (MTT) by the activity of mitochondrial de-
hydrogenases; in the neutral red uptake test (NRU) 
by the intensity of active membrane transfer pro-
cesses and lysosomal activity; in the sulforhodamine 
B test (SRB) [26].
The tests were conducted in three replications 
in two series of the experiment (n = 6). The LC50 cyto-
toxic concentration was calculated by probit analysis 
using SPSS 21 (SPSS Inc., USA) in each of the tests.
The genotoxic effect of the studied substances 
was evaluated in vitro using the comet DNA assay 
in alkaline conditions [27, 28]. Cells were incubated for 
18 h in the presence of cadmium compounds at con-
centrations of 2 • 106 and 8 • 107 mol/l (concentrations 
were selected based on their cytotoxic performance 
indicators). Cells that were incubated in the presence 
of 1 mmol of N-nitrosomethyl urea were used as a posi-
tive control, while intact cells served negative control. 
The tests were conducted in three replications in two 
series of experiment (n = 6).
Micro-preparations were analyzed by means 
of fluorescent microscopy, and “NA comets” visually. 
For this purpose the “DNA comets” were tentatively 
subdivided into five types, with each type assigned 
an appropriate number from 0 to 4. The degree of DNA 
damage was expressed as the “DNA comet” (IDNA) 
index, calculated using the following formula:
IDNA = (0n0 + 1n1 + 2n2 + 3n3 + 4n4) / Σ, 
where n0–n4 is the number of “DNA comets” of each 
type, and Σ is the sum of “DNA comets”. Alkaline gel 
electrophoresis method of the isolated cells (“DNA 
comets”), allowed to obtain electrophoretic tracks 
of the “comets” type in all positive control samples.
196 Experimental Oncology 40, 194–199, 2018 (September)
The primary data were statistically processed us-
ing Microsoft Excel 2003 and SPSS 21 (SPSS Inc., 
USA). The reliability of the differences between the 
scores was evaluated by Mann — Whitney U-test, 
with a significant difference between the scores 
being p < 0.05.
RESULTS AND DISCUSSION
Study of the cytotoxic effect of CdCl2 and CdS 
NPs on MАEC cell line culture. MАEC line cells 
were incubated for 24 h with different concentrations 
of CdCl2 and CdS NPs after which MTT, NRU, and 
SRB revealed a significant dose-dependent cytotoxic 
activity of the cadmium compounds studied, which 
indicates the similar direction of these compounds 
effect on the membranes permeability, mitochondrial 
and lysosomal activity, and the protein-synthesizing 
function of the MАEC line cells.
The results of the probit analysis show (Table 1) that 
according to the results of the three tests performed 
to assess the functional activity of the MАEC cells, 
the lowest cytotoxic concentration of LC50 (causing 
death of 50% of cells) was recorded under the effect 
of CdCl2, and the highest — under the effect of CdS NPs 
of 4–6 nm in size. This suggests that CdCl2 in the MАEC 
cells culture demonstrates a greater cytotoxic effect.
Study of cytotoxic effect of CdCl2 and CdS 
NPs on cell culture of IMR-32 line demonstrated 
cytotoxic effects in MTT, NRU and SRB аfter 24 h in-
cubation. When comparing the cytotoxic effect of the 
cadmium compounds studied on the IMR-32 cells 
culture by the value of LC50, it was established (see 
Table 1) that in the MTT and NRU tests the highest 
cytotoxic effect was observed in exposure to CdCl2, 
and in the SRB to CdS of 4–6 nm in size. This suggests 
that CdCl2 in cytotoxic doses is more likely to inhibit 
mitochondrial dehydrogenase activity, and CdS NPs — 
the protein biosynthesis and proliferative activity.
Table 1. Сytotoxic effect of CdCl2 and CdS NPs on cell culture in three 
functional tests, LС50 (95% confidence interval), mmol/l
Test NP of CdS4–6 nm NP of CdS9–11 nm CdCl2
MАEC cell culture
МТТ 0.073
(0.042–0.130)
0.051
(0.029—0.090)
0.053
(0.030—0.094)
NRU 0.076
(0.043—0.134)
0.076
(0.043—0.137)
0.025
(0.014—0.044)
SRB 0.166
(0.091—0.309)
0.104
(0.057—0.190)
0.040
(0.018—0.053)
IMR-32 cell culture
МТТ 0.090
(0.040—0.206)
0.113
(0.051—0.260)
0.054
(0.024—0.120)
NRU 0.101
(0.044—0.238)
0.081
(0.036—0.185)
0.041
(0.018—0.092)
SRB 0.086
(0.036—0.204)
0.166
(0.069—0.412)
0.134
(0.056—0.325)
НЕК-293 cell culture
МТТ 0.286
(0.091—0.974)
1.817
(0.432—9.223)
0.031
(0.011—0.086)
NRU 0.267
(0.084—0.922)
1.133
(0.308—4.987)
0.034
(0.011—0.099)
SRB 0.440
(0.130—1.648)
0.813
(0.223—3.362)
0.013
(0.004—0.038)
Study of the cytotoxic effect of CdCl2 and 
CdS NPs on НEК-293 cell line culture. Compara-
tive evaluation of the cytotoxic activity of the studied 
compounds according to the results of in MTT, NRU 
and SRB revealed that CdCl2 had the greatest cytotoxic 
effect on the cells of the НEК-293 line, and the effect 
of CdS NPs of 9–11 nm in size was the lowest. Accord-
ing to probit analyzes, the LC50 in these three tests was 
the lowest under the action of CdCl2, and the highest 
under the action of a CdS NPs of 9–11 nm in size.
Thus, the results of the study demonstrated pro-
nounced dose-dependent cytotoxic effect of CdS NPs 
and CdCl2 on the MАEC, НEК-293 and IMR-32 cell 
lines cultures leading to impaired membrane perme-
ability and functioning of mitochondria and lysosomes, 
and to suppressed function of protein synthesis. Cy-
totoxic action of CdCl2 was more pronounced (except 
the effect of CdS NPs 4–6 nm in size in the SRB test); 
the cytotoxic effect of mainly CdS (9–11 nm) was low. 
НEК-293 culture was the most sensitive to the cyto-
toxic activity of CdCl2, being less sensitive to both sizes 
of CdS NPs at the same time; and the MАEC cell line 
culture was most sensitive to the effect of CdS NPs. 
However, CdS NPs of both sizes in low doses that were 
not cytotoxic, caused an increase in cellular functional 
activity according to NRU and SRB tests as compared 
with intact cells, which may indirectly indicate stimula-
tion of their proliferative activity.
Study of genotoxic effect of CdCl2 and CdS 
NPs on cell cultures. According to the results of the 
study conducted with “DNA comets” assay in alkaline 
conditions on the cultures of the studied cell lines 
a statistically significant increase of the “DNA comet” 
index was observed compared to the negative control, 
indicating the genotoxic effect of CdCl2 and CdS NPs 
(Table 2). Moreover, the of НEК-293 cell culture was 
the most sensitive to the genotoxic effect of the stud-
ied cadmium compounds, with the IMR-32 being the 
least sensitive.
Results of the MАEC line cell culture study re-
vealed the lowest genotoxic effect of CdS NPs 
(9–11 nm) by “DNA comets” indices. The effects 
of CdS NPs (4–6 nm) and CdCl2 were similar, there 
being no statistical difference in “DNA comets” indices 
in these groups.
The DNA comet index in the study on IMR-32 cell 
line was the highest after incubation with 4–6 nm CdS 
NPs, being higher than that of the positive control. 
The DNA comet index was also high after incubation 
of cells with CdCl2.
The studies on the НEК-293 cell culture showed 
similar genotoxic effect of CdS NPs of both sizes 
and CdCl2: the indices of the “DNA comets” were 
higher than the negative control index and there was 
no statistically significant difference between the 
former two.
“DNA comet” assay in alkaline conditions on the 
cultures of the studied cell lines revealed a statistically 
significant increase in the DNA comet index compared 
to the negative control, which indicate the genotoxic 
effect of CdCl2 and CdS NPs. CdS NPs of 4–6 nm in size 
demonstrated a more pronounced genotoxic effect 
in comparison with a 9–11 nm NP.
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Cytotoxic activity of cadmium compounds NPs 
is largely due to the specific features of cadmium ac-
tion. Mechanisms for the development of cadmium 
intoxication have been studied by researchers for 
several decades. On different cell types it was shown 
that cadmium ions enter the cell through the calcium 
channels of the plasma membrane and bind to the 
cytoplasmic and nuclear material. In high concen-
tration cadmium inhibits biosynthesis of DNA, RNA 
and protein, causing DNA breaks and chromosomal 
aberrations [29]. Jie et al. [6] have shown that oxida-
tive stress plays an important role in the implementa-
tion of cytotoxic and genotoxic effect of cadmium 
and the development of apoptosis. In the studies 
on HepG2 cell culture CdCl2 caused a dose-dependent 
decrease in cell viability, stimulated lipid peroxidation 
due to the increased formation of ROS, induced DNA 
damage and caused apoptosis in cells [30].
Cadmium causes impairment of thiol homeostasis 
in a cell characterized by a decrease in glutathione 
levels and also by direct interaction with sulfhydryl 
groups of proteins due to their high affinity with 
them, which leads to their structural deformation and 
changes in the catalytic activity of enzymes [31], and 
also competes with Zn (II) in proteins and binds to the 
DNA bases causing single-stranded DNA breaks [32].
It has been reported that cadmium also modulates 
the expression of genes and signaling in a cell [33], 
increases the ROS production and inhibits the activity 
of antioxidant enzymes [34], prevents DNA repair [35]. 
Thus, our earlier studies have shown that cadmium 
impaired the expression of SNF1/AMP-activated pro-
tein kinase (SNARK) genes in experimental rats after 
subchronic exposure, which may lead to a disruption 
of signaling cascades in cells [36–38].
Results of in vitro experiments have shown cad-
mium to induce DNA damage in bacteria [39], cause 
single-stranded DNA breaks and disrupt the synthesis 
of nucleic acids and proteins [40]. In low concentra-
tions cadmium stimulates DNA synthesis and cell 
proliferation, it also increases the expression of early 
genes (c-fos, c-jun, and c-myc), the p53 tumor sup-
pressor gene, as well as genes encoding the synthesis 
of protective molecules, including metallothioneins, 
glutathione, and stress proteins (thermal shock), in-
dicating modification of cellular signaling processes, 
phosphorylation of proteins, and transcription fac-
tors [41].
Researchers distinguish two important ways of mu-
tagenesis under effect of cadmium: increased ROS 
production and stimulation of oxidative DNA damage, 
as well as inhibition of DNA repair, which reduces ge-
netic stability of the cell and increases the likelihood 
of mutations [42].
Thus, the following processes underlie the impair-
ment of homeostatic mechanisms in the cell under the 
effect of cadmium: increased production of ROS and 
inhibition of the antioxidant system, the development 
of oxidative stress and stimulation of lipid peroxidation, 
impairment of calcium homeostasis and signaling pro-
cesses, direct interaction of cadmium with sulfhydryl 
groups of proteins, leading to changes in the activity 
of enzymes, which plays an important role in the imple-
mentation of cytotoxic and genotoxic effects.
Taking into account the specifics of the NPs effect 
on the cell, one can assume that cadmium compounds 
in nanoform, especially of small sizes up to 5 nm, will 
exhibit more pronounced cytotoxic and genotoxic ef-
fects compared to the ionic form.
The above-mentioned mechanisms for the imple-
mentation of cytotoxic action of cadmium underlie 
carcinogenic induction. As discussed previously, 
cadmium causes cancers in experimental animals 
at multiple tissue sites. Huff et al. [8] believe that the 
mechanism of carcinogenicity is multi-factorial. Like 
other toxic metals cadmium may act with the help 
of molecular/atomic mimicry of essential nutrient 
metals, zink and selenium in particular, which take 
an active part in proliferation processes. It has a wide 
spectrum of cellular and molecular effects, including 
both genetic and epigenetic ones, which could affect 
all stages in the carcinogenic process.
Cadmium-induced biochemical changes may play 
roles in all stages of carcinogenicity (initiation, pro-
motion, and progression). For example: 1) induction 
of oxidative stress in combination with decreased DNA 
repair can lead to DNA damage, and gene mutation, 
resulting in preneoplastic lesions; 2) aberrant gene 
expression and signaling in combination with inhibi-
tion of DNA methylation induce proto-oncogenes 
which results in cell proliferation; and 3) E-cadherin 
dysfunction disrupts cell adhesion and causes tumor 
progression. Moreover, сadmium compounds are co-
mutagens in mammalian cells when combined with 
genotoxic agents [43].
Summarizing the results of the above, we can draw 
the following conclusions. Cadmium compounds, both 
in ionic form (CdCl2) and in nanoform (CdS NPs) exhibit 
pronounced dose-dependent cytotoxic and genotoxic 
effects. CdCl2 showed more pronounced cytotoxic ac-
tivity, compared to the CdS NPs (of MАEC, НEК-293); 
at the same time, CdS NPs of 9-11 nm in size had 
Table 2. Indices of DNA comets of cells after incubation with CdCl2 and CdS NPs, Me (Q25; Q75), mmol/l
Cell culture NP of CdS4-6 nm NP of CdS9-11 nm CdCl2 Control2 • 10-6 mol/l 8 • 10-7 mol/l 2 • 10-6 mol/l 8 • 10-7 mol/l 2 • 10-6 mol/l 8 • 10-7 mol/l Positive Negative
МAEC 1.95*
(1.88; 2.13)
1.90*
(1.88; 2.05)
0.85*#^
(0.78; 1.13)
0.90*#^
(0.88; 1.10)
2.00*
(1.88; 2.13)
1.95*
(1.95; 2.10)
2.40*
2.30; 2.58)
0.15
(0.10; 0.23)
НEК-293 1.00*
(0.88; 1.20)
1.00*
(0.90; 1.13)
1.00*
(0.88; 1.13)
0.95*
(0.88; 1.10)
1.05*
(0.90; 1.20)
1.00*
(0.88; 1.20)
1.15*
(1.05; 1.20)
0.15
(0.10; 0.23)
IMR-32 2.10*^
(1.98; 2.25)
1.85*
(1.78; 1.93)
0.70*#^
(0.70; 0.83)
0.90*#^
(0.88; 1.03)
1.90*
(1.90; 2.03)
1.95*
(1.88; 2.03)
1.75*
(1.68; 1.83)
0.25
(0.18; 0.30)
Note: *Statistically significant as compared to intact cells (with negative control); #statistically significant as compared to effect of CdS NPs of various si zes; 
^statistically significant as compared to CdS NPs and CdCl2; by Mann — Whitney U-test, with statistically significant difference between indices p < 0.05.
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a lower toxic effect, in comparison with 4–6 nm CdS 
NPs. Cadmium compounds caused an increase in the 
index of DNA comets. CdS NPs of 9–11 nm in size ex-
hibited a lower genotoxic effect, compared with NPs 
of 4–6 nm and CdCl2.
The identification of mechanisms for the imple-
mentation of toxic effects of cadmium compounds 
NPs will allow to assess the potential risks associated 
with their use in industry and to develop effective pre-
ventive measures. In particular, when planning in vivo 
studies in toxicological evaluation of nanomaterials 
and NPs containing cadmium NPs, it is necessary 
to study the mutagenic and carcinogenic risks, and 
also to take into account the high likelihood of develop-
ment of neurotoxic and cardiovasotoxic effects, along 
with nephrotoxic effects, as the high cytotoxic activity 
of the investigated cadmium compounds was detected 
on the cells of the MАEC cell line of endothelial origin 
and IMR-32 cells of neuronal origin.
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